Clobazam Suspension
Product Images NDC 16714-087

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 16714-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cartonlabel (Cartonlabel)

Carton label for Clobazam Oral Suspension 2.5 mg/mL by NorthStar Rx LLC. The label indicates a 120 mL oral suspension with instructions to shake well before use and store at controlled room temperature. Manufactured by Hetero Labs Limited, India. The label includes NDC 16714-087-01 and a barcode.*

FDA Label Image

Containerlabel (Containerlabel)

Clobazam Oral Suspension 2.5 mg/mL labeled for oral administration only, manufactured by NorthStar Rx LLC. The label includes instructions for use, storage conditions (20°C to 25°C), and a pharmacist advisory to dispense the Medication Guide separately. The bottle size is 120 mL, with packaging details and barcode visible.*

FDA Label Image

Figure--a (Figure A)

Clobazam Oral Suspension 2.5 mg/mL in a 120 mL amber glass bottle with a white child-resistant cap. The image includes the product carton labeled Clobazam Oral Suspension 2.5 mg/mL by NorthStar RxLLC and two purple oral syringes along with a bottle adapter for oral administration. The packaging displays the NDC 16714-087-01 and indicates the medication is for prescription use only.*

FDA Label Image

Figure--i (Figure I)

Clobazam Oral Suspension 2.5 mg/mL in a brown glass bottle with a white child-resistant cap, partially unscrewed by a hand. The label shows the product name, strength, and that it is an oral suspension. The labeler is NorthStar RxLLC.*

FDA Label Image

Figure-b (Figure B)

Bottle of Clobazam oral suspension 2.5 mg/mL in amber glass with a white child-resistant cap. The label indicates it is for oral administration only and includes instructions to shake well before use. The bottle is being held in a person's hand, emphasizing the shake well instruction. The labeler is NorthStar RxLLC, and the bottle contains 120 mL of suspension.*

FDA Label Image

Figure-c (Figure C)

An instructional image showing a hand removing or placing a white child-resistant cap on an amber glass bottle, likely demonstrating bottle opening or closing for an oral suspension.*

FDA Label Image

Figure-d (Figure D)

An instructional illustration of an oral syringe labeled with parts including dosage indicators, tip, barrel, plunger, and violet ring on the plunger. This diagram is related to dosing a liquid medication such as the Clobazam 2.5 mg/mL oral suspension by NorthStar RxLLC.*

FDA Label Image

Figure-e (Figure E)

An instructional illustration showing a hand holding a purple oral dosing syringe inserted into the opening of a brown glass bottle, demonstrating the method for withdrawing Clobazam 2.5 mg/mL oral suspension from the bottle using the syringe. A downward arrow alongside indicates the direction for syringe insertion or liquid withdrawal.*

FDA Label Image

Figure-f (Figure F)

An instructional image showing a person drawing oral suspension medicine into a purple syringe from a brown bottle. The liquid moves upward into the syringe, and a black arrow points downward toward the syringe tip, illustrating the proper method to prepare an oral dose of suspension medication, such as Clobazam 2.5 mg/mL oral suspension by NorthStar RxLLC.*

FDA Label Image

Figure-g (Figure G)

An instructional illustration showing a brown bottle dispensing a purple liquid into an oral dosing syringe. The syringe features clear volume markings with an arrow pointing to a "violet ring" on the syringe, indicating the target measure level for dosing.*

FDA Label Image

Figure-h (Figure H)

An illustration showing a child receiving oral medication via a dosing syringe. The syringe is inserted into the child's mouth to administer a liquid suspension, likely representing how to deliver Clobazam oral suspension.*

FDA Label Image

Graph (Graph)

A bar chart showing percentage reduction in weekly drop seizures across four groups: Placebo, Low, Medium, and High. The reductions range from about -12% for Placebo to approximately -68% for the High group, indicating increasing seizure reduction with dosage.*

FDA Label Image

Graph2 (Graph2)

A bar chart showing the proportion of patients (%) on the vertical axis and reduction in weekly drop seizure frequency from baseline (%) on the horizontal axis, with groups labeled Placebo, Clobazam Low, Clobazam Medium, and Clobazam High.*

FDA Label Image

Structure (Structure)

Chemical structure of Clobazam, showing its molecular arrangement with a chlorinated benzodiazepine core, including a methyl group and two ketone functionalities in the benzodiazepine ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.